Alibaba
BABA
Apple
AAPL
Netflix
NFLX
Tesla
TSLA
Microsoft
MSFT
US Stock MarketDetailed Quotes
ADPT Adaptive Biotechnologies
- 8.220
- -0.020-0.24%
Close Mar 27 16:00 ET
- 8.220
- 0.0000.00%
Post 16:38 ET
1.22BMarket Cap-7.61P/E (TTM)
8.530High7.990Low3.12MVolume8.170Open8.240Pre Close25.91MTurnover3.24%Turnover RatioLossP/E (Static)148.58MShares9.01052wk High6.03P/B793.04MFloat Cap2.28052wk Low--Dividend TTM96.48MShs Float71.250Historical High--Div YieldTTM6.55%Amplitude2.280Historical Low8.298Avg Price1Lot Size
Adaptive Biotechnologies News
Insider Sale: Chief Scientific Officer of $ADPT Sells 1,698 Shares
Goldman Sachs Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $9
Scholastic Posts Strong Earnings, Joins Ouster, Torrid Holdings, Adaptive Biotechnologies And Other Big Stocks Moving Higher On Friday
Goldman Sachs Upgrades Adaptive Biotechnologies(ADPT.US) to Buy Rating, Raises Target Price to $9
Goldman Sachs Upgrades Adaptive Biotechnologies to Buy From Neutral, Adjusts Price Target to $9 From $8
Adaptive Biotechnologies (ADPT): Among Stocks Insiders Are Selling In March
BTIG Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Maintains Target Price $10
Adaptive Biotechnologies (ADPT) Gets a Buy From BTIG
The 9.1% Return This Week Takes Adaptive Biotechnologies' (NASDAQ:ADPT) Shareholders One-year Gains to 129%
Top Executives Cash In on Adaptive Biotechnologies Stock!
Adaptive Biotechnologies Launches Assay Enhancements to Increase ClonoSEQ Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma
Adaptive Biotechnologies | 10-K: FY2024 Annual Report
Cathie Wood's Ark Invest Loads Up On Beam Therapeutics, Nu Holdings: Offloads MercadoLibre, Adaptive Biotechnologies
Piper Sandler Maintains Adaptive Biotechnologies(ADPT.US) With Buy Rating, Raises Target Price to $11
Piper Sandler Sticks to Their Buy Rating for Adaptive Biotechnologies (ADPT)
Insider Sale: CEO and Chairman of $ADPT Sells 211,160 Shares
Adaptive Biotechnologies(ADPT.US) Officer Sells US$3.99 Million in Common Stock
Insiders At Adaptive Biotechnologies Sold US$626k In Stock, Alluding To Potential Weakness
BTIG Initiates Adaptive Biotechnologies(ADPT.US) With Buy Rating, Announces Target Price $10
Adaptive Biotechnologies Is Maintained at Sector Outperform by Scotiabank
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
